1. Sanofi-a Ventis Deutschland Gmbh (11 from 1,827 patents)

2. Sanofi-aventis (9 from 389 patents)

3. Aventis Pharma Deutschland, Gmbh (9 from 330 patents)

4. Sanofi (8 from 1,451 patents)

5. California Institute of Technology (3 from 4,547 patents)

1. 11090364 - Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein

2. 9966443 - Nanopillar field-effect and junction transistors with functionalized gate and base electrodes

3. 9960238 - Nanopillar field-effect and junction transistors with functionalized gate and base electrodes

4. 9070733 - Nanopillar field-effect and junction transistors with functionalized gate and base electrodes

5. 9029400 - 5-oxoisoxazoles as inhibitors of lipases and phospholipases

6. 8933024 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases

7. 8921404 - Azole derivatives in the form of lipase and phospholipase inhibitors

8. 8735437 - Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors

9. 8357698 - Diacyl indazole derivatives as lipase and phospholipase inhibitors

10. 8148395 - Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases

11. 8008331 - Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors

12. 7968719 - Indazole derivatives as inhibitors of hormone sensitive lipase

13. 7897625 - Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases

14. 7897616 - Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases

15. 7846943 - Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors